primary human coronary artery smooth muscle cells (hcsmc) Search Results


human colonic smooth muscle cells (hcsmc  (ScienCell)
90
ScienCell human colonic smooth muscle cells (hcsmc
Human Colonic Smooth Muscle Cells (Hcsmc, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+coronary+artery+smooth+muscle+cells+%28hcsmc%29/10__1074_slash_jbc__m115__678979-130-0-16?v=ScienCell
Average 90 stars, based on 1 article reviews
human colonic smooth muscle cells (hcsmc - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
human coronary arterial smcs (hcsmcs  (Lonza)
90
Lonza human coronary arterial smcs (hcsmcs
Human Coronary Arterial Smcs (Hcsmcs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+coronary+artery+smooth+muscle+cells+%28hcsmc%29/pm28429615-26-0-8?v=Lonza
Average 90 stars, based on 1 article reviews
human coronary arterial smcs (hcsmcs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
human cerebral microvascular smcs (hcsmcs  (ScienCell)
90
ScienCell human cerebral microvascular smcs (hcsmcs
Human Cerebral Microvascular Smcs (Hcsmcs, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+coronary+artery+smooth+muscle+cells+%28hcsmc%29/pmc05738666-226-13-23?v=ScienCell
Average 90 stars, based on 1 article reviews
human cerebral microvascular smcs (hcsmcs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
human coronary smooth muscle cells (csmc)  (CellSystems Biotechnologie Vertrieb GmbH)
90
CellSystems Biotechnologie Vertrieb GmbH human coronary smooth muscle cells (csmc)
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Human Coronary Smooth Muscle Cells (Csmc), supplied by CellSystems Biotechnologie Vertrieb GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+coronary+artery+smooth+muscle+cells+%28hcsmc%29/pmc02676633-25-0-8?v=CellSystems+Biotechnologie+Vertrieb+GmbH
Average 90 stars, based on 1 article reviews
human coronary smooth muscle cells (csmc) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
hcsmcs  (Lonza)
90
Lonza hcsmcs
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Hcsmcs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+coronary+artery+smooth+muscle+cells+%28hcsmc%29/pmc04090713-115-19-25?v=Lonza
Average 90 stars, based on 1 article reviews
hcsmcs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
primary hcsmcs  (Cell Applications Inc)
95
Cell Applications Inc primary hcsmcs
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Primary Hcsmcs, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+coronary+artery+smooth+muscle+cells+%28hcsmc%29/pm33959644-101-0-5?v=Cell+Applications+Inc
Average 95 stars, based on 1 article reviews
primary hcsmcs - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier
hcsmc  (Lonza)
90
Lonza hcsmc
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Hcsmc, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+coronary+artery+smooth+muscle+cells+%28hcsmc%29/10__1096_slash_fj__202001062r-49-0-7?v=Lonza
Average 90 stars, based on 1 article reviews
hcsmc - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
hcsmcs  (ScienCell)
90
ScienCell hcsmcs
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Hcsmcs, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+coronary+artery+smooth+muscle+cells+%28hcsmc%29/pmc05226563-158-0-2?v=ScienCell
Average 90 stars, based on 1 article reviews
hcsmcs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
vitro primary human coronary artery smooth muscle cells hcsmcs  (Cell Applications Inc)
92
Cell Applications Inc vitro primary human coronary artery smooth muscle cells hcsmcs
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Vitro Primary Human Coronary Artery Smooth Muscle Cells Hcsmcs, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+coronary+artery+smooth+muscle+cells+%28hcsmc%29/pm36306211-45-29-41?v=Cell+Applications+Inc
Average 92 stars, based on 1 article reviews
vitro primary human coronary artery smooth muscle cells hcsmcs - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier
human coronary smooth muscle cells  (BioWhittaker Molecular Applications)
90
BioWhittaker Molecular Applications human coronary smooth muscle cells
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Human Coronary Smooth Muscle Cells, supplied by BioWhittaker Molecular Applications, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+coronary+artery+smooth+muscle+cells+%28hcsmc%29/pm16313278-36-0-6?v=BioWhittaker+Molecular+Applications
Average 90 stars, based on 1 article reviews
human coronary smooth muscle cells - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
human ciliary smooth muscle (hcsm) cells  (alcon inc)
90
alcon inc human ciliary smooth muscle (hcsm) cells
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Human Ciliary Smooth Muscle (Hcsm) Cells, supplied by alcon inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+coronary+artery+smooth+muscle+cells+%28hcsmc%29/pm09472468-61-4-20?v=alcon+inc
Average 90 stars, based on 1 article reviews
human ciliary smooth muscle (hcsm) cells - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells (CSMC) (A), CSMC treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.

Journal: International Journal of Nanomedicine

Article Title: Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles

doi:

Figure Lengend Snippet: Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells (CSMC) (A), CSMC treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.

Article Snippet: Human coronary smooth muscle cells (CSMC), purchased from CellSystems Biotechnologies GmbH, had no more than 9 doublings when used in the experiments.

Techniques: Transfection, Double Staining, Synthesized

Summarized cell cycle phase distribution data. Cell cycle phase distribution was evaluated for non-treated cells human coronary smooth muscle cells (CSMC), CSMC treated by a commonly used transfection reagent (liposome), and poly(DL-lactide-co-glycolide) (PLGA) microparticles. Data are reported as means ± SD (n=3). No statistically significant differences were noted among the different treatments.

Journal: International Journal of Nanomedicine

Article Title: Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles

doi:

Figure Lengend Snippet: Summarized cell cycle phase distribution data. Cell cycle phase distribution was evaluated for non-treated cells human coronary smooth muscle cells (CSMC), CSMC treated by a commonly used transfection reagent (liposome), and poly(DL-lactide-co-glycolide) (PLGA) microparticles. Data are reported as means ± SD (n=3). No statistically significant differences were noted among the different treatments.

Article Snippet: Human coronary smooth muscle cells (CSMC), purchased from CellSystems Biotechnologies GmbH, had no more than 9 doublings when used in the experiments.

Techniques: Transfection